Since 2011, the ATTUNE® Knee System has been provided for more than 700,000 patients worldwide.1
The ATTUNE® Knee System has shown statistically significant improvements in patient recorded outcomes compared to certain leading brands.2
In a clinical study, physical therapists noted that ATTUNE Knee patients had significantly greater range of motion compared to another leading knee replacement, both two and six weeks postsurgery.3
Hear surgeons and patients discuss their experience with the ATTUNE Knee System.
1. ATTUNE® Knee System Unit Sales 2018. DePuy Orthopaedics, Inc. 2. Hamilton WG, Brenkel I, Clatworthy M, et al. Comparison of an Existing and New Total Knee Arthroplasty Implant System from the Same Manufacturer. A Prospective, Multicenter Study. Podium Presentation at Closed Meeting of the Knee Society. Sept 2018, St Louis, MO, USA. SRR 10850. 3. Clatworthy, M. (2015). An Early Outcome Study of the ATTUNE® Knee System vs. the SIGMA® CR150 Knee System. DePuy Synthes Companies White Paper. DSUS/JRC/0814/0418 (1). In an IRB approved early outcomes study, physiotherapists collected data on 40 patients implanted with ATTUNE® Knees and 40 patients with SIGMA® CR150 knees. The results demonstrated that patients implanted with the ATTUNE Knee had statistically significant improvements in some early outcomes, other outcomes demonstrated a trend favoring the ATTUNE Knee, and some outcomes were equivalent.